Connexions GSK plc

GSK

GB00BN7SWP63

Produits pharmaceutiques

Marché Fermé - London S.E. Autres places de cotation 17:35:14 17/07/2026			Varia. 5j.	Varia. 1 janv.
1 916,50 ^GBX	-2,02%		-2,29%	+5,04%

17/07	Le FTSE 100 progresse, porté par les services publics et l'énergie ; Andy Burnham prend la tête du Parti travailliste	RE
17/07	Les actions européennes cotées aux États-Unis sous forme d'ADR en repli ce vendredi	MT

49

Sociétés cotées

50

Entreprise privées

732

Insiders

Graphique Relationnel des Sociétés Cotées liées: GSK plc

Relations Actives

Relations Passées

Sociétés Cotées liées: GSK plc

Christopher Viehbacher

Mene Pangalos

SONY GROUP CORPORATION

Wendy Becker

BIOMARIN PHARMACEUTICAL INC.

Elizabeth Anderson

VODAFONE GROUP PLC

Simon Dingemans

Anne-Françoise Nesmes

INSMED INCORPORATED

Elizabeth Anderson

SANOFI

Anne-Françoise Nesmes

Christopher Corsico

OXFORD NANOPORE TECHNOLOGIES PLC

WAVE LIFE SCIENCES LTD.

RECKITT BENCKISER GROUP PLC

Deborah Waterhouse

LIXIL CORPORATION

Hwa Jin Song Montesano

YAMAHA MOTOR CO., LTD.

Hwa Jin Song Montesano

MELIÁ HOTELS INTERNATIONAL, S.A.

María Cristina de Luna Basagoiti

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

Subesh Williams

GENMAB A/S

Deirdre Connelly

Paolo Augusto Paoletti

VISCOFAN, S.A.

María Cristina de Luna Basagoiti

ASPEN PHARMACARE HOLDINGS LIMITED

David Redfern

JCR PHARMACEUTICALS CO., LTD.

ALNYLAM PHARMACEUTICALS, INC.

Yvonne Greenstreet

Stuart Arbuckle

GLAXOSMITHKLINE PAKISTAN LIMITED

Dmytro Oliinyk

INOVIO PHARMACEUTICALS, INC.

CANDEL THERAPEUTICS, INC.

REVOLUTION MEDICINES, INC.

SURGERY PARTNERS, INC.

Teresa DeLuca

COGNETIVITY NEUROSCIENCES LTD.

Mark Phillips

SHATTUCK LABS, INC.

Thomas Lampkin

Arunthathy Nirmalini Pandite

GENENTA SCIENCE S.P.A.

Carlo Russo

John Cantello

PRAXIS PRECISION MEDICINES, INC.

Dean Mitchell

Stuart Arbuckle

LB PHARMACEUTICALS INC

Robert Ruffolo

CAMP4 THERAPEUTICS CORPORATION

Murray Stewart

KODIAK SCIENCES INC.

Charles Bancroft

X4 PHARMACEUTICALS, INC.

BRII BIOSCIENCES LIMITED

Zhi Hong

Lisa Trivison Beck

LIFESTANCE HEALTH GROUP, INC.

PERSPECTIVE THERAPEUTICS, INC.

Maya Martinez-Davis

ELICIO THERAPEUTICS, INC.

Robert Ruffolo

Carol Ashe

Relations Actives

Relations Passées

Graphique Relationnel des Sociétés Privées liées: GSK plc

Relations Actives

Relations Passées

Entreprise Privées liées: GSK plc

Human Genome Sciences, Inc.

Medical Specialties

Adrian Rawcliffe

Dan Troy

David Redfern

Healthcare Businesswomens Association

Miscellaneous Commercial Services

Jim Weiss

Allene Diaz

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Elicio Therapeutics, Inc. (United States)

Biotechnology

Robert Ruffolo

Carol Ashe

Duke University

Other Consumer Services

Allen W. Mangel

Gwendolyn Powell Painter

University of Oxford

Other Consumer Services

Crispin Davis

Wendy Becker

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Julie Brown

Ian Maurice Gray Prosser

The American Institute of Certified Public Accountants

Miscellaneous Commercial Services

Christopher Chipman

Paul Hawran

Cancer Research Institute

Medical/Nursing Services

Laurie Glimcher

Jim Weiss

Protez Pharmaceuticals, Inc.

Pharmaceuticals: Major

Peter A. Sears

Luigi Xerri

The Royal Society of Chemistry

Miscellaneous Commercial Services

Richard Sykes

Brian D. Morgan

Kyowa Kirin International Plc

Pharmaceuticals: Major

Paul Carter

Thomas Stratford

GlaxoSmithKline, Inc.

Pharmaceuticals: Major

Christopher Gent

Andrew Witty

University of the Sciences in Philadelphia

Other Consumer Services

Kent E. Lieginger

Catherine Sohn

Council on Foreign Relations, Inc.

Investment Trusts/Mutual Funds

George Poste

James Murdoch

Norgine Pharmaceuticals Ltd.

Pharmaceuticals: Major

Richard Taylor

Jo Pillai

ProPharma Partners Ltd.

Miscellaneous Commercial Services

Peter J. Cozens

Jill Rasmussen

The Institute of International Finance, Inc.

Miscellaneous Commercial Services

Tom de Swaan

Urs Rohner

Lifearc

Miscellaneous Commercial Services

Ian Gilham

Michael Anthony Romanos

New York State Bar Association

Miscellaneous Commercial Services

James R. Beery

Urs Rohner

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Judy Lewent

Laurie Glimcher

Lucy Shapiro

National Academy of Medicine (United States)

Miscellaneous Commercial Services

The Royal College of Physicians

Other Consumer Services

James Shannon

David Clark

Pennsylvania Institute of Certified Public Accountants

Miscellaneous Commercial Services

Christopher Chipman

Paul Hawran

Hatteras Venture Partners

Investment Managers

Charlie Sanders

John Lepore

The Business Council

Miscellaneous Commercial Services

John A. Young

Larry Culp

Scarab Genomics LLC

Biotechnology

Martin Rosenberg

Richard Lesniewski

Springboard Enterprises, Inc.

Internet Software/Services

Lauren Flanagan

Amy Millman

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Joseph Feczko

Jim Weiss

Confederation of British Industry

Miscellaneous Commercial Services

Ian Maurice Gray Prosser

Vindi Banga

The Bioindustry Association

Miscellaneous Commercial Services

Peter J. Cozens

Chris Molloy

Michael Anthony Romanos

Harvard Medical School

Other Consumer Services

Laurie Glimcher

Yvonne Greenstreet

European Financial Services Round Table

Miscellaneous Commercial Services

Tom de Swaan

Urs Rohner

British Pharmacological Society

Investment Trusts/Mutual Funds

Dimitri Dimitriou

Heather Giles

Mene Pangalos

The Cancer Prevention & Research Institute of Texas

Biotechnology

Elaine Jones

Jack Geltosky

ViiV Healthcare Ltd.

Pharmaceuticals: Major

John Apeler Keller

David Redfern

Autifony Therapeutics Ltd.

Pharmaceuticals: Major

Elaine Jones

Charles H. Large

Giuseppe S. Alvaro

Belle Capital Management LLC

Investment Managers

Irene Hrusovsky

Lauren Flanagan

Amy Millman

Stanford University School of Medicine

Other Consumer Services

Lucy Shapiro

Christopher Viehbacher

Saïd Business School

Other Consumer Services

Dame Cox

Vindi Banga

Wendy Becker

Genomics England Ltd.

Miscellaneous Commercial Services

Jonathan Symonds

Eliot Forster

Office for Strategic Co-ordination of Health Research

Eliot Forster

Patrick J. T. Vallance

GlaxoSmithKline Consumer Healthcare Holdings Ltd.

Financial Conglomerates

Simon Dingemans

David Redfern

Brian McNamara

GlaxoSmithKline Intellectual Property Holdings Ltd.

Financial Conglomerates

Simon Dingemans

Paul Blackburn

Sapience Therapeutics, Inc.

Biotechnology

Robert Ruffolo

Howard H. Pien

Cardior Pharmaceuticals GmbH

Pharmaceuticals: Major

Russell Greig

Ulrich Granzer

Gammadelta Therapeutics Ltd.

Biotechnology

Peter Goodfellow

Michael Owen

Avacta Life Sciences Ltd.

Pharmaceuticals: Major

Eliot Forster

Michael Owen

Avaana Capital Advisors LLP

Investment Managers

Anjali Bansal

Relations Actives

Relations Passées

Statistiques des Connexions

Actives

Inactives

Sociétés cotées

Entreprise privées

Activités des Sociétés liées

Pharmaceuticals: Major	26
Miscellaneous Commercial Services	20
Biotechnology	17
Other Consumer Services	7
Medical/Nursing Services	3
Investment Managers	3
Medical Specialties	3
Motor Vehicles	2
Internet Software/Services	2
Financial Conglomerates	2

Pays des Sociétés liées

Etats-Unis	48
Royaume-Uni	26
Japon	4
Allemagne	3
France	3
Canada	2
Danemark	2
Inde	2
Espagne	2
Belgique	1

GSK plc est le 2e groupe pharmaceutique mondial. Le CA par famille de produits se répartit comme suit : - produits pharmaceutiques (41,3%) : destinés notamment au traitement de l'infection par le VIH (57% du CA), des maladies respiratoires et des troubles du système immunitaire (28,3%) et des cancers (14,7%) ; - médicaments OTC et parapharmaceutiques (30,7%) ; - vaccins (28%). La répartition géographique du CA est la suivante : Royaume-Uni (2,1%), Europe (21%), Etats-Unis (51,6%) et autres (25,3%).

Employés

66 841

Secteur

Produits pharmaceutiques

Agenda

28/07 - Publication des résultats - Q2 2026

Plus d'informations sur la société